Cytosorbents
CTSO
#10672
Rank
โ‚ฌ18.2 M
Marketcap
0,29ย โ‚ฌ
Share price
-1.41%
Change (1 day)
-64.01%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚ฌ10.51 Million

According to Cytosorbents's latest financial reports the company's current earnings are โ‚ฌ37.2 Million. In 2025 the company made an earning of -โ‚ฌ7.43 Million, an increase over its 2024 earnings that were of -โ‚ฌ19.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ10.51 Million41.5%
2025 -โ‚ฌ7.43 Million-62.16%
2024 -โ‚ฌ19.62 Million-22.49%
2023 -โ‚ฌ25.31 Million-13.52%
2022 -โ‚ฌ29.27 Million34.04%
2021 -โ‚ฌ21.83 Million182.17%
2020 -โ‚ฌ7.74 Million-55.97%
2019 -โ‚ฌ17.57 Million14.17%
2018 -โ‚ฌ15.39 Million95.14%
2017 -โ‚ฌ7.89 Million-22.32%
2016 -โ‚ฌ10.16 Million39.1%
2015 -โ‚ฌ7.3 Million-12.89%
2014 -โ‚ฌ8.38 Million89%
2013 -โ‚ฌ4.44 Million26.65%
2012 -โ‚ฌ3.5 Million-26.02%
2011 -โ‚ฌ4.74 Million-288.45%
2010 โ‚ฌ2.51 M-4.17%
2009 โ‚ฌ2.61 M-287.19%
2008 -โ‚ฌ1.4 Million-47.12%
2007 -โ‚ฌ2.65 Million41.78%
2006 -โ‚ฌ1.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚ฌ3.22 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ0.67 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
โ‚ฌ47.9 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA